Search Results

The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.

PharmaLogic Holdings Corp. announced the opening of its new radiopharmaceutical production and research facility in Cincinnati, Ohio.

Cincinnati Children’s has begun work on an Applied Gene and Cell Therapy Center, which will enable the health system to increase clinical trials of innovative drugs and biological therapeutics for patients with cancer, blood diseases or genetic disorders.

Danaher Corporation, a global science and technology innovator, launched a strategic collaboration with Cincinnati Children’s Hospital Medical Center, with the goal of improving patient safety by addressing a leading cause of failure in clinical trials.

Cincinnati Children’s, the top ranked pediatric hospital and top ranked cancer program in the country by U.S. News & World Report, continues to break new ground with the launch of the first of its kind Advanced Leukemia Therapies and Research Center.

Our latest Research Annual Report, online now, recounts a remarkable year of scientific advancement supported by a record-high level of research funding from federal, state, industry and philanthropic sources.

Varian and the Cincinnati Children’s/University of Cincinnati Medical Center Proton Therapy Center, today announced clinical trial results from FAST-01 (FeAsibility Study of Flash Radiotherapy for the Treatment of Symptomatic Bone Metastases), the first clinical trial of ultra-high dose rate Flash therapy and the first-in-human experience of proton Flash.